Skip to main content

Table 1 Partners in the safety lead-in phase of the MARSYAS II study

From: Safety and clinical efficacy of the secretome of stressed peripheral blood mononuclear cells in patients with diabetic foot ulcer—study protocol of the randomized, placebo-controlled, double-blind, multicenter, international phase II clinical trial MARSYAS II

Sponsor

Aposcience AG

CRO

FGK Clinical Research GmbH

Service provider for IMP storage and distribution

ABF Pharmaceutical Services GmbH

Drug manufacturer

Austrian Red Cross, Blood Transfusion Service for Upper Austria

Safety lead-in

 Study center 1

Kepler Universitaetsklinikum Linz

 Study center 2

A.oe. Krankenhaus der Elisabethinen Klagenfurt

 Backup study center 1

Fakultní nemocnice u sv. Anny, Brno

 Backup study center 2

Fakultní nemocnice Královské Vinohrady, Prague

 Backup study center 3

Ústřední vojenská nemocnice - Vojenská fakultní nemocnice, Prague

Back to article page

Trials

ISSN: 1745-6215